Literature DB >> 19949989

Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer.

Shelby K Wyatt1, H Charles Manning, Mingfeng Bai, Stephanie N Bailey, Pascal Gallant, Guobin Ma, Laura McIntosh, Darryl J Bornhop.   

Abstract

PURPOSE: To quantitatively evaluate the utility of a translocator protein (TSPO)-targeted near-infrared (NIR) probe (NIR-conPK11195) for in vivo molecular imaging of TSPO in breast cancer. PROCEDURES: NIR-conPK11195 uptake and TSPO-specificity were validated in TSPO-expressing human breast adenocarcinoma cells (MDA-MB-231). In vivo NIR-conPK11195 biodistribution and accumulation were quantitatively evaluated in athymic nude mice bearing MDA-MB-231 xenografts.
RESULTS: Fluorescence micrographs illustrated intracellular labeling of MDA-MB-231 cells by NIR-conPK11195. Quantitative uptake and competition assays demonstrated dose-dependent (p < 0.001) and TSPO-specific (p < 0.001) NIR-conPK11195 uptake. In vivo, NIR-conPK11195 preferentially labeled MDA-MB-231 tumors with an 11-fold (p < 0.001) and 7-fold (p < 0.001) contrast enhancement over normal tissue and unconjugated NIR dye, respectively.
CONCLUSIONS: NIR-conPK11195 appears to be a promising TSPO-targeted molecular imaging agent for visualization and quantification of breast cancer cells in vivo. This research represents the first study to demonstrate the feasibility of TSPO imaging as an alternative breast cancer imaging approach.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949989      PMCID: PMC6544016          DOI: 10.1007/s11307-009-0270-8

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  53 in total

1.  Diagnostic imaging of breast cancer using fluorescence-enhanced optical tomography: phantom studies.

Authors:  A Godavarty; A B Thompson; R Roy; M Gurfinkel; M J Eppstein; C Zhang; E M Sevick-Muraca
Journal:  J Biomed Opt       Date:  2004 May-Jun       Impact factor: 3.170

2.  Synthesis and biology of a 7-nitro-2,1,3-benzoxadiazol-4-yl derivative of 2-phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptor.

Authors:  A P Kozikowski; M Kotoula; D Ma; N Boujrad; W Tückmantel; V Papadopoulos
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

Review 3.  Optical imaging: current applications and future directions.

Authors:  Gary D Luker; Kathryn E Luker
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

Review 4.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Prog Neurobiol       Date:  2006-12-06       Impact factor: 11.685

5.  Time-domain optical mammography SoftScan: initial results.

Authors:  Xavier Intes
Journal:  Acad Radiol       Date:  2005-08       Impact factor: 3.173

6.  Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.

Authors:  I C Smith; A E Welch; A W Hutcheon; I D Miller; S Payne; F Chilcott; S Waikar; T Whitaker; A K Ah-See; O Eremin; S D Heys; F J Gilbert; P F Sharp
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

Review 7.  Whole-body optical imaging in animal models to assess cancer development and progression.

Authors:  Eric L Kaijzel; Gabri van der Pluijm; Clemens W G M Löwik
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

8.  Binding characteristics of SSR180575, a potent and selective peripheral benzodiazepine ligand.

Authors:  V Vin; N Leducq; F Bono; J M Herbert
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

Review 9.  Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications.

Authors:  Wendy DeMartini; Constance Lehman; Savannah Partridge
Journal:  Acad Radiol       Date:  2008-04       Impact factor: 3.173

Review 10.  PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.

Authors:  S D Jonson; M J Welch
Journal:  Q J Nucl Med       Date:  1998-03
View more
  12 in total

1.  Multispectral fluorescence imaging to assess pH in biological specimens.

Authors:  Matthew R Hight; Donald D Nolting; Eliot T McKinley; Adam D Lander; Shelby K Wyatt; Mark Gonyea; Ping Zhao; H Charles Manning
Journal:  J Biomed Opt       Date:  2011 Jan-Feb       Impact factor: 3.170

2.  Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.

Authors:  Dewei Tang; Michael L Nickels; M Noor Tantawy; Jason R Buck; H Charles Manning
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

3.  Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging.

Authors:  Dewei Tang; Jun Li; Jason R Buck; Mohamed Noor Tantawy; Yan Xia; Joel M Harp; Michael L Nickels; Jens Meiler; H Charles Manning
Journal:  Mol Imaging Biol       Date:  2017-08       Impact factor: 3.488

4.  N-[18F]-Fluoroacetylcrizotinib: A potentially potent and selective PET tracer for molecular imaging of non-small cell lung cancer.

Authors:  Jason R Buck; Samir Saleh; Trey Claus; Christine Lovly; Matthew R Hight; Michael L Nickels; M Noor Tantawy; H Charles Manning
Journal:  Bioorg Med Chem Lett       Date:  2020-06-02       Impact factor: 2.823

5.  A self-internalizing mitochondrial TSPO targeting imaging probe for fluorescence, MRI and EM.

Authors:  Lynn E Samuelson; Bernard M Anderson; Mingfeng Bai; Madeline J Dukes; Colette R Hunt; Jonathon D Casey; Zeqiu Han; Vassilios Papadopoulos; Darryl J Bornhop
Journal:  RSC Adv       Date:  2014-01-03       Impact factor: 3.361

6.  Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo.

Authors:  Steven T Proulx; Paola Luciani; Annamari Alitalo; Viviane Mumprecht; Ailsa J Christiansen; Reto Huggenberger; Jean-Christophe Leroux; Michael Detmar
Journal:  Angiogenesis       Date:  2013-01-17       Impact factor: 9.596

7.  TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions.

Authors:  Allison S Cohen; Jun Li; Matthew R Hight; Eliot McKinley; Allie Fu; Adria Payne; Yang Liu; Dawei Zhang; Qing Xie; Mingfeng Bai; Gregory D Ayers; Mohammed Noor Tantawy; Jarrod A Smith; Frank Revetta; M Kay Washington; Chanjuan Shi; Nipun Merchant; H Charles Manning
Journal:  Clin Cancer Res       Date:  2020-09-15       Impact factor: 12.531

8.  Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging.

Authors:  Dewei Tang; Eliot T McKinley; Matthew R Hight; Md Imam Uddin; Joel M Harp; Allie Fu; Michael L Nickels; Jason R Buck; H Charles Manning
Journal:  J Med Chem       Date:  2013-04-03       Impact factor: 7.446

9.  Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer.

Authors:  Yiu-Yin Cheung; Michael L Nickels; Dewei Tang; Jason R Buck; H Charles Manning
Journal:  Bioorg Med Chem Lett       Date:  2014-08-08       Impact factor: 2.823

10.  Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma.

Authors:  Dewei Tang; Jun Li; Michael L Nickels; Gang Huang; Allison S Cohen; H Charles Manning
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.